Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06). (Q53632971)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06). |
scientific article |
Statements
Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06). (English)
1 reference
D Koeberle
1 reference
D C Betticher
1 reference
R von Moos
1 reference
D Dietrich
1 reference
P Brauchli
1 reference
D Baertschi
1 reference
K Matter
1 reference
R Winterhalder
1 reference
M Borner
1 reference
S Anchisi
1 reference
P Moosmann
1 reference
A Kollar
1 reference
P Saletti
1 reference
A Roth
1 reference
M Frueh
1 reference
M Kueng
1 reference
R A Popescu
1 reference
S Schacher
1 reference
V Hess
1 reference
R Herrmann
1 reference
20 January 2015
1 reference
26
1 reference
709-714
1 reference
4
1 reference
Identifiers
1 reference